Innovation - Elusive, Hard to Measure but Essential: Philip Cross in the National Review
Capitalism best cultivates innovation because it provides the incentive for firms to survive and thrive as well as the freedom to explore, writes...
The Pandemic: High-water Mark for Government Intervention?: Philip Cross for Inside Policy
The response of governments was heavy-handed, lead-footed, and wrong-headed, writes Philip Cross. By Philip Cross, December 8, 2020 2020 forever will be associated...
Seizing pharma profits kills pharma investment: Richard Owens in the Financial Post
It’s time, well past time, for government to get out of the way of innovation and put the health and well-being of Canadians...
Standing on Guard - Why We Need to Secure Canadian technology and Innovators from the PRC: Henry Geraedts and Shuvaloy Majumdar for Inside Policy
The PRC will likely consolidate and step up its successful illicit technology acquisition programs to meet its needs, write Henry Geraedts and Shuvaloy...
GTIPA Virtual Summit 2020
On October 29, the Global Trade and Innovation Policy Alliance will be holding a summit bringing together alliance members and experts from around...
Lack of innovation is crippling Maritime recovery: Philip Cross in the Telegraph Journal
Implementing changes to bolster a more entrepreneurial culture will take time, but less than the decades already wasted on government efforts to boost...
COVID-19 destroyed. Now we must let innovators create: Philip Cross in the Financial Post
Growing our economy requires cultivating an entrepreneurial mindset, not grandiose plans for more government spending, writes Philip Cross in the Financial Post. Below is...
New MLI paper by Philip Cross: Fixing Canada’s Chronic Lack of Innovation
OTTAWA, ON (September 15, 2020): As the Canadian economy recovers from the devastation wrought by the COVID-19 pandemic and subsequent lockdown, Canada’s ability...
COVID-19 Highlights Weaknesses in Canada’s System for New Medicines: MLI report by Rawson and Adams
OTTAWA, ON (June 18, 2020): The COVID-19 pandemic has revealed numerous weaknesses in Canadian health care, and as the world races for new...
Econ 101: Drug price controls shrink supply: Richard Owens in the Financial Post
Increased drug revenues enable increased research and development expenditures, which in turn result in better health and longer lives, writes Richard Owens. By...
